Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies
Genetic epilepsies are a spectrum of disorders characterized by spontaneous and recurrent seizures that can arise from an array of inherited or de novo genetic variants and disrupt normal brain development or neuronal connectivity and function. Genetically determined epilepsies, many of which are du...
Main Authors: | Kimberly Goodspeed, Rachel M. Bailey, Suyash Prasad, Chanchal Sadhu, Jessica A. Cardenas, Mary Holmay, Deborah A. Bilder, Berge A. Minassian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.805007/full |
Similar Items
-
SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy
by: Kimberly Goodspeed, et al.
Published: (2022-09-01) -
Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system
by: Emily M. Spelbrink, et al.
Published: (2023-03-01) -
A case of Gitelman syndrome with homozygous SLC12A3 deletion presenting with epilepsy
by: Ying Wang, et al.
Published: (2023-11-01) -
Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder
by: Sanjana Kalvakuntla, et al.
Published: (2023-02-01) -
Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes
by: Zhihui Li, et al.
Published: (2021-12-01)